KLYG logo

Kelyniam Global, Inc. Stock Price

OTCPK:KLYG Community·US$5.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

KLYG Share Price Performance

US$0.12
-0.08 (-42.00%)
US$0.12
-0.08 (-42.00%)
Price US$0.12

KLYG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Kelyniam Global, Inc. Key Details

US$2.7m

Revenue

US$636.3k

Cost of Revenue

US$2.0m

Gross Profit

US$2.3m

Other Expenses

-US$218.5k

Earnings

Last Reported Earnings
Dec 31, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About KLYG

Founded
2005
Employees
n/a
CEO
Ross Bjella
WebsiteView website
www.kelyniam.com

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Canton, Connecticut.

Recent KLYG News & Updates

Recent updates

No updates